These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35287254)

  • 1. Analysis of Once-Daily Thoracic Radiotherapy Dose According to the Underlying Lung Disease in Patients with Limited-Stage Small Cell Lung Cancer Undergoing Concurrent Chemoradiotherapy.
    Kim BH; Chung JH; Son J; Kim S; Wu HG; Kim HJ
    Cancer Res Treat; 2023 Jan; 55(1):73-82. PubMed ID: 35287254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effectiveness of aggressive thoracic radiation therapy and concurrent chemoradiation therapy in metastatic lung cancer.
    Koshy M; Malik R; Mahmood U; Rusthoven CG; Sher DJ
    Pract Radiat Oncol; 2015; 5(6):374-82. PubMed ID: 26412340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
    Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
    Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A Phase I/II Study of Chemotherapy Concurrent with Twice-daily Radiotherapy 
Schedules by Intensity Modulated Radiation Therapy Using Simultaneous Integrated Boost for Limited-stage Small Cell Lung Cancer].
    You J; Yu H; Song M; Shi C; Wang X; Zheng Y; Yu R; Shi A; Zhu G
    Zhongguo Fei Ai Za Zhi; 2017 Jan; 20(1):28-34. PubMed ID: 28103970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phase I Study of Etoposide and Cisplatin Chemotherapy Dose Escalation 
with Concurrent Twice-daily Radiotherapy for Patients 
with Limited-stage Small Cell Lung Cancer].
    You J; Yu H; Song M; Shi C; Wang X; Zheng Y; Yu R; Shi A; Zhu G
    Zhongguo Fei Ai Za Zhi; 2017 Jan; 20(1):55-60. PubMed ID: 28103974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pooled analysis of limited-stage small-cell lung cancer patients treated with induction chemotherapy followed by concurrent platinum-based chemotherapy and 70 Gy daily radiotherapy: CALGB 30904.
    Salama JK; Hodgson L; Pang H; Urbanic JJ; Blackstock AW; Schild SE; Crawford J; Bogart JA; Vokes EE;
    J Thorac Oncol; 2013 Aug; 8(8):1043-9. PubMed ID: 23715301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Routine use of approximately 60 Gy once-daily thoracic irradiation for patients with limited-stage small-cell lung cancer.
    Miller KL; Marks LB; Sibley GS; Clough RW; Garst JL; Crawford J; Shafman TD
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):355-9. PubMed ID: 12738309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twice-daily thoracic radiotherapy by intensity-modulated radiation therapy (IMRT) compared with simultaneous integrated boost IMRT (SIB-IMRT) with concurrent chemotherapy for patients with limited-stage small cell lung cancer. A propensity-score matched analysis.
    Sun H; Liu C; Zhang J; Yang G; Han D; Liu T; Huang W; Li B
    Radiother Oncol; 2022 Jul; 172():140-146. PubMed ID: 35101460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of survival outcomes among standard radiotherapy regimens in limited-stage small cell lung cancer patients receiving concurrent chemoradiation.
    Rutter CE; Park HS; Corso CD; Yeboa DN; Mancini BR; Lester-Coll NH; Kim AW; Decker RH
    Lung Cancer; 2015 Nov; 90(2):243-8. PubMed ID: 26277031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twice-daily vs higher-dose once-daily thoracic radiotherapy for limited-disease small-cell lung cancer: A PRISMA-compliant meta-analysis.
    Yang L; Liu L; Yang Y; Lei Y; Wang T; Wu X; Guo X
    Medicine (Baltimore); 2020 Jul; 99(27):e20518. PubMed ID: 32629632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538.
    Bogart J; Wang X; Masters G; Gao J; Komaki R; Gaspar LE; Heymach J; Bonner J; Kuzma C; Waqar S; Petty W; Stinchcombe TE; Bradley JD; Vokes E
    J Clin Oncol; 2023 May; 41(13):2394-2402. PubMed ID: 36623230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overall survival and toxicities regarding thoracic three-dimensional radiotherapy with concurrent chemotherapy for stage IV non-small cell lung cancer: results of a prospective single-center study.
    Su SF; Hu YX; Ouyang WW; Lu B; Ma Z; Li QS; Li HQ; Geng YC
    BMC Cancer; 2013 Oct; 13():474. PubMed ID: 24118842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial.
    Grønberg BH; Killingberg KT; Fløtten Ø; Brustugun OT; Hornslien K; Madebo T; Langer SW; Schytte T; Nyman J; Risum S; Tsakonas G; Engleson J; Halvorsen TO
    Lancet Oncol; 2021 Mar; 22(3):321-331. PubMed ID: 33662285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No survival benefit with early incorporation of thoracic radiotherapy using daily fractionation in patients with limited-stage small cell lung cancer undergoing chemoradiotherapy in the modern era: A systematic review and meta-analysis.
    Kim BH; Song C; Kim HJ
    Radiother Oncol; 2023 Jul; 184():109696. PubMed ID: 37150449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of elderly patients with limited-stage small-cell lung cancer after combined chemoradiotherapy.
    Su J; Zhu S; Liu Z; Li J; Shen W; Li R
    Am J Ther; 2014; 21(5):371-6. PubMed ID: 22975663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypo- or conventionally fractionated radiotherapy combined with chemotherapy in patients with limited stage small cell lung cancer.
    Zhang J; Fan M; Liu D; Zhao KL; Wu KL; Zhao WX; Zhu ZF; Fu XL
    Radiat Oncol; 2017 Mar; 12(1):51. PubMed ID: 28283034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated hypofractionated thoracic radiotherapy in limited disease small cell lung cancer : comparison with the results of conventionally fractionated radiotherapy.
    Socha J; Guzowska A; Tyc-Szczepaniak D; Wierzchowski M; Sprawka A; Szczesna A; Kepka L
    J BUON; 2015; 20(1):146-57. PubMed ID: 25778310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shifting from hypofractionated to "conventionally" fractionated thoracic radiotherapy: a single institution's 10-year experience in the management of limited-stage small-cell lung cancer using concurrent chemoradiation.
    Videtic GM; Truong PT; Dar AR; Yu EW; Stitt LW
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):709-16. PubMed ID: 14529775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Might radiation therapy in addition to chemotherapy improve overall survival of patients with non-oligometastatic Stage IV non-small cell lung cancer?: Secondary analysis of two prospective studies.
    Su S; Hu Y; Ouyang W; Ma Z; Li Q; Li H; Wang Y; Wang X; Li T; Li J; Chen M; Lu Y; Bai Y; He Z; Lu B
    BMC Cancer; 2016 Nov; 16(1):908. PubMed ID: 27871270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent chemotherapy is associated with improved survival in elderly patients with bladder cancer undergoing radiotherapy.
    Korpics MC; Block AM; Martin B; Hentz C; Gaynor ER; Henry E; Harkenrider MM; Solanki AA
    Cancer; 2017 Sep; 123(18):3524-3531. PubMed ID: 28581675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.